Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (180) 180
Journal Article (107) 107
Book / eBook (7) 7
Publication (6) 6
Book Review (4) 4
Book Chapter (3) 3
Magazine Article (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (178) 178
hygiene (178) 178
medical or veterinary science (178) 178
preparations for medical, dental, or toilet purposes (178) 178
specific therapeutic activity of chemical compounds ormedicinal preparations (134) 134
chemistry (120) 120
metallurgy (120) 120
organic chemistry (90) 90
heterocyclic compounds (84) 84
general tagging of cross-sectional technologies spanning over several sections of the ipc (69) 69
general tagging of new technological developments (69) 69
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (69) 69
index medicus (65) 65
biochemistry (57) 57
microbiology (54) 54
beer (53) 53
compositions thereof (53) 53
culture media (53) 53
enzymology (53) 53
humans (53) 53
microorganisms or enzymes (53) 53
mutation or genetic engineering (53) 53
propagating, preserving or maintaining microorganisms (53) 53
spirits (53) 53
vinegar (53) 53
wine (53) 53
technologies for adaptation to climate change (45) 45
technologies or applications for mitigation or adaptation againstclimate change (45) 45
investigating or analysing materials by determining theirchemical or physical properties (38) 38
measuring (38) 38
physics (38) 38
testing (38) 38
animals (35) 35
immunology (32) 32
imiquimod (24) 24
technical subjects covered by former uspc (24) 24
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (24) 24
aminoquinolines - pharmacology (23) 23
compositions or test papers therefor (23) 23
condition-responsive control in microbiological orenzymological processes (23) 23
female (23) 23
measuring or testing processes involving enzymes, nucleicacids or microorganisms (23) 23
mice (23) 23
processes of preparing such compositions (23) 23
male (18) 18
adjuvants, immunologic - pharmacology (16) 16
cells, cultured (16) 16
cytokines - biosynthesis (16) 16
abridged index medicus (15) 15
cell biology (15) 15
toll-like receptor 7 - agonists (15) 15
adhesives (14) 14
dyes (14) 14
imidazoles - pharmacology (14) 14
lakes (14) 14
miscellaneous applications of materials (14) 14
miscellaneous compositions (14) 14
mordants (14) 14
natural resins (14) 14
organic dyes or closely-related compounds for producing dyes (14) 14
paints (14) 14
polishes (14) 14
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (13) 13
cytokines (13) 13
guinea-pigs (13) 13
materials for miscellaneous applications, not provided forelsewhere (13) 13
toll-like receptor 8 - agonists (13) 13
bandages, dressings or absorbent pads (11) 11
devices providing patency to, or preventing collapsing of,tubular structures of the body, e.g. stents (11) 11
filters implantable into blood vessels (11) 11
first-aid kits (11) 11
fomentation (11) 11
interferon inducers - pharmacology (11) 11
orthopaedic, nursing or contraceptive devices (11) 11
prostheses (11) 11
treatment or protection of eyes or ears (11) 11
dendritic cells (10) 10
interferon (10) 10
toll-like receptors (10) 10
adult (9) 9
immunomodulators imiquimod (9) 9
cytokines - genetics (8) 8
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (8) 8
innate immunity (8) 8
middle aged (8) 8
processes using microorganisms (8) 8
t-cells (8) 8
adjuvant (7) 7
cardiac & cardiovascular systems (7) 7
cytokine (7) 7
dendritic cells - immunology (7) 7
forestry (7) 7
induction (7) 7
infection (7) 7
lymphocyte activation - drug effects (7) 7
mice, inbred c57bl (7) 7
pharmacology & pharmacy (7) 7
responses (7) 7
adjuvants, immunologic - administration & dosage (6) 6
administration, topical (6) 6
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Music - Stacks (1) 1
Online Resources - Online (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (271) 271
French (74) 74
German (37) 37
Spanish (8) 8
Norwegian (7) 7
Czech (5) 5
Hungarian (5) 5
Portuguese (4) 4
Danish (2) 2
Japanese (2) 2
Chinese (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Introduction to human factors and ergonomics for engineers
by Lehto, Mark R and Buck, James R. joint author
2007, Human factors & ergonomics, ISBN 9780805853087
Book
Details down arrow
2. Full Text Abstracts of the HIV Research for Prevention Meeting, HIVR4P, 17-20 October, 2016, Chicago, USA
by Sullivan, Patrick and Yuan, Maoli and Coleman, John and Destefano, Joanne and Zhang, Xinsheng and Yates, Nicole and Barouch, Dan and Ackerman, Margaret and Decamp, Allan and Alter, Galit and Tomaras, Georgia and Tomaras, Georgia and Montefiori, David and Montefiori, David and Rasmussen, Beth and Morrow, Gavin and Koff, Wayne and Kashuba, Angela and Kashuba, Angela and Mascola, John and Picker, Louis and Kent, Stephen and Selhorst, Philippe and Masson, Lindi and Ngandu, Nobubelo and Rademeyer, Cecilia and Karim, Quarraisha Abdool and Kijak, Gustavo and Barouch, Dan and Rasheed, Ata Ur and Havenar-Daughton, Colin and Pham, Matthew and Kovalenkov, Yevgeniy and Gumber, Sanjeev and Johnson, Matthew and Wrammert, Jens and Villinger, Francois and Haynes, Barton and Haynes, Barton and Fox, Christopher and Reed, Steve and Vasilakos, John and Tomai, Mark and Crotty, Shane and Ahmed, Rafi and Pulendran, Bali and Fukazawa, Yoshinori and Lifson, Jeffrey and Lifson, Jeffrey and Moore, Penny and Chatora, Kumbirai and Skorochod, Elisabeth and Madidi, Ngonidzashe and Gomez, Anabel and Ncube, Getrude and Sundaram, Maaya and Kretschmer, Steve and Pauthner, Matthias and Briney, Bryan and Lee, Jeong Hyun and Saye-Francisco, Karen and Hsueh, Jessica and Ramos, Alejandra and Le, Khoa and Jones, Meaghan and Jardine, Joseph and Bastidas, Raiza and Sarkar, Anita and Liang, Chi-Hui and Wilson, Ian and Ward, Andrew and Zhu, Jiang and Poignard, Pascal and Burton, Dennis and Krebs, Shelly and Law, Wiliam and Gift, Syna and Chenine, Agnes and Rolland, Morgane and Moody, M. Anthony and Jarosinski, Marissa and Georgiev, Ivelin and Chuang, Gwo-Yu and Chuang, Gwo-Yu and Asokan, Mangaiarkarasi and Bailer, Robert T and Cale, Evan M and Louder, Mark and Kwong, Peter D and Polonis, Victoria and Tovanabutra, Sodsai and Robb, Merlin and Mascola, John R and Wibmer, Constantinos Kurt and Wibmer, Constantinos Kurt and Madzorera, Vimbai S and Doria-Rose, Nicole A and Morris, Lynn and Moore, Penny L and Anthony, Colin and ...
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2016, Volume 32, Issue S1, pp. 1 - 409
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
: National Harbor, MD, USA. 9-13 November 2016
by Ager, Casey and Reilley, Matthew and Nicholas, Courtney and Bartkowiak, Todd and Jaiswal, Ashvin and Curran, Michael and Albershardt, Tina C and Bajaj, Anshika and Archer, Jacob F and Reeves, Rebecca S and Ngo, Lisa Y and Berglund, Peter and ter Meulen, Jan and Denis, Caroline and Ghadially, Hormas and Arnoux, Thomas and Chanuc, Fabien and Fuseri, Nicolas and Wilkinson, Robert W and Wagtmann, Nicolai and Morel, Yannis and Andre, Pascale and Atkins, Michael B and Carlino, Matteo S and Ribas, Antoni and Thompson, John A and Choueiri, Toni K and Hodi, F. Stephen and Hwu, Wen-Jen and McDermott, David F and Atkinson, Victoria and Cebon, Jonathan S and Fitzharris, Bernie and Jameson, Michael B and McNeil, Catriona and Hill, Andrew G and Mangin, Eric and Ahamadi, Malidi and van Vugt, Marianne and van Zutphen, Mariëlle and Ibrahim, Nageatte and Long, Georgina V and Gartrell, Robyn and Blake, Zoe and Simoes, Ines and Fu, Yichun and Saito, Takuro and Qian, Yingzhi and Lu, Yan and Saenger, Yvonne M and Budhu, Sadna and De Henau, Olivier and Zappasodi, Roberta and Schlunegger, Kyle and Freimark, Bruce and Hutchins, Jeff and Barker, Christopher A and Wolchok, Jedd D and Merghoub, Taha and Burova, Elena and Allbritton, Omaira and Hong, Peter and Dai, Jie and Pei, Jerry and Liu, Matt and Kantrowitz, Joel and Lai, Venus and Poueymirou, William and MacDonald, Douglas and Ioffe, Ella and Mohrs, Markus and Olson, William and Thurston, Gavin and Capasso, Cristian and Frascaro, Federica and Carpi, Sara and Tähtinen, Siri and Feola, Sara and Fusciello, Manlio and Peltonen, Karita and Martins, Beatriz and Sjöberg, Madeleine and Pesonen, Sari and Ranki, Tuuli and Kyruk, Lukasz and Ylösmäki, Erkko and Cerullo, Vincenzo and Cerignoli, Fabio and Xi, Biao and Guenther, Garret and Yu, Naichen and Muir, Lincoln and Zhao, Leyna and Abassi, Yama and Cervera-Carrascón, Víctor and Siurala, Mikko and Santos, João and Havunen, Riikka and Parviainen, Suvi and Hemminki, Akseli and ...
Journal for ImmunoTherapy of Cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue S1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1–dependent pathways
by Philbin, Victoria J., DPhil and Dowling, David J., PhD and Gallington, Leighanne C., BSc and Cortés, Guadalupe, PhD and Tan, Zhen, MD and Suter, Eugénie E., MA and Chi, Kevin W., BA and Shuckett, Ariel, MPH and Stoler-Barak, Liat, MSc and Tomai, Mark, PhD and Miller, Richard L., PhD and Mansfield, Keith, DVM and Levy, Ofer, MD, PhD
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2012, Volume 130, Issue 1, pp. 195 - 204.e9
Background Newborns have frequent infections and manifest impaired vaccine responses, motivating a search for neonatal vaccine adjuvants. Alum is a neonatal... 
Allergy and Immunology | adenosine | innate immunity | adjuvant | inflammasome | neonate | Toll-like receptor 8 | newborn | IL-1β | caspase-1 | alum | IL-1 beta | IMMUNOLOGY | VACCINE ADJUVANTS | RESPONSES | IMMUNIZATION | MAGNITUDE | ALLERGY | ALPHA PRODUCTION | BASIC MECHANISMS | TLR7 | EXPRESSION | Cytokines - metabolism | Adjuvants, Immunologic | Dendritic Cells - immunology | Humans | Caspase 1 - metabolism | Imidazoles - pharmacology | Macaca mulatta | Monocytes - immunology | Quinolines - pharmacology | Alum Compounds | Animals | Adenosine - metabolism | Adult | Infant, Newborn | Cytokines - immunology | Toll-Like Receptor 8 - agonists | Drugs | Infants (Newborn) | Medical colleges | Drug delivery systems | RNA | Dendritic cells | Cross infection | Children | Nosocomial infections | Adenylic acid | Vehicles | Diseases | Hepatitis | Adenosine | Cytokines | Newborn babies | Aluminum | Immune system | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists
by Gorski, Kevin S and Waller, Emily L and Bjornton-Severson, Jacqueline and Hanten, John A and Riter, Christie L and Kieper, William C and Gorden, Keith B and Miller, Jeffrey S and Vasilakos, John P and Tomai, Mark A and Alkan, Sefik S
International Immunology, ISSN 0953-8178, 07/2006, Volume 18, Issue 7, pp. 1115 - 1126
NK cells limit the emergence of cancers and viral infections by surveillance of 'missing-self' and 'induced-self' ligands, and by direct recognition of... 
Toll-like receptors | Cytotoxicity | NK cells | Cytokines | IMMUNE-RESPONSE | NATURAL-KILLER-CELLS | DOUBLE-STRANDED-RNA | IFN-GAMMA | IMMUNOLOGY | CPG DNA | PLASMACYTOID DENDRITIC CELLS | MHC CLASS-I | ADAPTIVE IMMUNITY | CYTOKINE PRODUCTION | cytokines | cytotoxicity | Toll-Like Receptor 7 - agonists | Antigens, CD - immunology | Antigens, Differentiation, T-Lymphocyte - immunology | Humans | Lectins, C-Type | Imidazoles - pharmacology | Quinolines - pharmacology | Toll-Like Receptor 8 - immunology | Lymphocyte Activation - immunology | Animals | Receptors, Interferon - immunology | Signal Transduction - drug effects | Lymphocyte Activation - drug effects | Mice, Mutant Strains | Toll-Like Receptor 7 - immunology | K562 Cells | Killer Cells, Natural - immunology | Ligands | Mice | Cytokines - immunology | Interferon Inducers - pharmacology | Toll-Like Receptor 8 - agonists | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica
by Abhyankar, Mayuresh M and Noor, Zannatun and Tomai, Mark A and Elvecrog, James and Fox, Christopher B and Petri, William A
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 6, pp. 916 - 922
Highlights • Nanoliposome adjuvant induced a robust mucosal and systemic response towards an amebiasis antigen. • Vaccine induced mucosal IgA inhibited... 
Allergy and Immunology | Liposome | Vaccine | Amebiasis | Immune response | Entamoeba | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNITY | PROTECTION | INTESTINAL AMEBIASIS | T-CELL | IMMUNOLOGY | SUBUNIT VACCINE | B-CELLS | IMMUNIZATION | RESPONSES | RETINOIC ACID | LECTIN | Entamoeba histolytica - immunology | Oligodeoxyribonucleotides - administration & dosage | Adjuvants, Immunologic - administration & dosage | Antigens, Protozoan - immunology | Liposomes - administration & dosage | Lipopolysaccharides - administration & dosage | Interleukin-17 - immunology | Protozoan Vaccines - chemistry | Entamoebiasis - immunology | Immunity, Mucosal - drug effects | Toll-Like Receptor 8 - immunology | Entamoebiasis - parasitology | Adjuvants, Immunologic - chemistry | Toll-Like Receptor 7 - immunology | Mice, Inbred CBA | Polysorbates - administration & dosage | Toll-Like Receptor 3 - genetics | Lectins - chemistry | Membrane Glycoproteins - immunology | Entamoeba histolytica - growth & development | Liposomes - immunology | Toll-Like Receptor 8 - agonists | Toll-Like Receptor 7 - agonists | Toll-Like Receptor 7 - genetics | Immunization | Tretinoin - administration & dosage | Vaccines, Subunit | Antigens, Protozoan - chemistry | Lectins - immunology | Protozoan Vaccines - immunology | Membrane Glycoproteins - agonists | Squalene - administration & dosage | Toll-Like Receptor 3 - immunology | Toll-Like Receptor 3 - agonists | Interleukin-17 - biosynthesis | Protozoan Vaccines - administration & dosage | Entamoeba histolytica - drug effects | Antibodies, Protozoan - biosynthesis | Membrane Glycoproteins - genetics | Liposomes - chemistry | Animals | Interferon-gamma - immunology | Entamoebiasis - prevention & control | Toll-Like Receptor 8 - genetics | Mice | RNA - administration & dosage | Alum Compounds - administration & dosage | Interferon-gamma - biosynthesis | Vaccination | Drugs | Evaluation | Antigens | Drug delivery systems | Communicable diseases | Mortality | Lectins | Drug therapy, Combination | Cells | Vehicles | Tretinoin | Studies | Aqueous solutions | Cytokines | Ligands | Vaccines | Experiments | Tropical diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. TLR-7 and -8 agonists as vaccine adjuvants
by Tomai, Mark A and Vasilakos, John P
Expert Review of Vaccines, ISSN 1476-0584, 04/2011, Volume 10, Issue 4, pp. 405 - 407
vaccine | adjuvant | TLR-8 | imiquimod | TLR-7 | resiquimod | imidazoquinoline | NONHUMAN-PRIMATES | IMMUNE-RESPONSE | IMMUNOLOGY | TOLL-LIKE-RECEPTOR-7 | CPG ODN | MODIFIER R-848 | IMMUNIZATION | T-CELL RESPONSES | MOUSE MODEL | TOLL-LIKE RECEPTORS | Toll-Like Receptor 7 - agonists | Neoplasms - therapy | Adjuvants, Immunologic - pharmacology | Animals | Humans | Vaccines - immunology | Neoplasms - prevention & control | Communicable Disease Control | Toll-Like Receptor 8 - agonists
Journal Article
Details down arrow
8. Full Text A Formulated TLR7/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines
by Van Hoeven, Neal and Fox, Christopher B and Granger, Brian and Evers, Tara and Joshi, Sharvari W and Nana, Ghislain I and Evans, Sarah C and Lin, Susan and Liang, Hong and Liang, Li and Nakajima, Rie and Felgner, Philip L and Bowen, Richard A and Marlenee, Nicole and Hartwig, Airn and Baldwin, Susan L and Coler, Rhea N and Tomai, Mark and Elvecrog, James and Reed, Steven G and Carter, Darrick
Scientific Reports, ISSN 2045-2322, 2017, Volume 7, Issue 1, pp. 46426 - 46426
Since 1997, highly pathogenic avian influenza viruses of the H5N1 subtype have been transmitted from avian hosts to humans. The severity of H5N1 infection in... 
IMMUNOGENICITY | VIRUS-INFECTION | RESPIRATORY DROPLET | PROTECTION | SAFETY | A H5N1 VACCINE | MULTIDISCIPLINARY SCIENCES | PHASE-II | ANTIBODY-RESPONSES | BALB/C MICE | CHILDREN | Toll-Like Receptor 7 - agonists | Adjuvants, Immunologic | Influenza A Virus, H5N1 Subtype - immunology | Humans | Influenza Vaccines | Influenza, Human - prevention & control | Toll-Like Receptor 8 - agonists | Antigens | Animal models | Pandemics | TLR7 protein | Clinical trials | Outbreaks | Vaccines | Avian flu | Disease transmission | Molecular modelling | Toll-like receptors | Hemagglutinins | Public health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Daily or Weekly Therapy with Resiquimod (R-848) Reduces Genital Recurrences in Herpes Simplex Virus-Infected Guinea Pigs during and after Treatment
by David I. Bernstein and Christopher J. Harrison and Mark A. Tomai and Richard L Miller
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2001, Volume 183, Issue 6, pp. 844 - 849
The effect of resiquimod (R-848), an immune-response modifier that is similar to imiquimod, on recurrent herpes simplex virus (HSV) was evaluated using the... 
Control groups | Simplexvirus | Genitalia | Cytokines | Major Articles | Human herpesvirus 2 | Antibodies | Viruses | Infections | Dosage | Genital herpes | INFECTIOUS DISEASES | TYPE-2 INFECTION | CYTOKINE INDUCTION | IMMUNOTHERAPY | S-28463 | IMMUNE-RESPONSE MODIFIER | SUPPRESSION | HSV-2 INFECTION | IMMUNOLOGICAL RESPONSES | IMIQUIMOD | ADJUVANT | Antibodies, Viral - biosynthesis | Interferons - biosynthesis | Guinea Pigs | Drug Administration Schedule | Cells, Cultured | Immunologic Factors - administration & dosage | Imidazoles - administration & dosage | Secondary Prevention | Random Allocation | Antigens, Viral - immunology | Animals | Herpes Genitalis - prevention & control | Herpesvirus 2, Human - immunology | Time Factors | Herpes Genitalis - virology | Leukocytes, Mononuclear - immunology | Female | Imidazoles - therapeutic use | Drug Evaluation, Preclinical | Herpes Genitalis - immunology | Interleukin-2 - biosynthesis | Immunologic Factors - therapeutic use | Herpes genitalis | Antiviral agents | Evaluation | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A Randomized, Controlled, Molecular Study of Condylomata Acuminata Clearance during Treatment with Imiquimod
by Stephen K. Tyring and Istvan Arany and Margaret A. Stanley and Mark A. Tomai and Richard L. Miller and Michael H. Smith and Daniel J. McDermott and Herbert B. Slade
The Journal of Infectious Diseases, ISSN 0022-1899, 8/1998, Volume 178, Issue 2, pp. 551 - 555
Imiquimod, an immune response modifier, has been demonstrated to be safe and effective in the treatment of external genital and perianal warts caused by human... 
Warts | Genitalia | Messenger RNA | Cytokines | DNA | Condylomata acuminata | Concise Communications | Biopsies | Viruses | Erythema | Vehicles | IMMUNITY | INFECTIOUS DISEASES | PAPILLOMAVIRUS-ASSOCIATED LESIONS | INFECTION | INTERFERON-BETA | Imiquimod | Cytokines - analysis | Humans | Condylomata Acuminata - virology | Genital Diseases, Female - pathology | Male | Genital Diseases, Male - pathology | Condylomata Acuminata - immunology | Genital Diseases, Male - drug therapy | Adult | Female | Cytokines - genetics | Genital Diseases, Female - virology | Genital Diseases, Male - virology | Genital Diseases, Female - immunology | Treatment Outcome | Condylomata Acuminata - pathology | Genital Diseases, Male - immunology | Interferon Inducers - therapeutic use | Adolescent | Genital Diseases, Female - drug therapy | Administration, Topical | Aminoquinolines - therapeutic use | RNA, Messenger | Condylomata Acuminata - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach
by Fox, Christopher B and Orr, Mark T and Van Hoeven, Neal and Parker, Sarah C and Mikasa, Traci J.T and Phan, Tony and Beebe, Elyse A and Nana, Ghislain I and Joshi, Sharvari W and Tomai, Mark A and Elvecrog, James and Fouts, Timothy R and Reed, Steven G
Journal of Controlled Release, ISSN 0168-3659, 12/2016, Volume 244, Issue Pt A, pp. 98 - 107
For nearly a century, aluminum salts have been the most widely used vaccine adjuvant formulation, and have thus established a history of safety and efficacy.... 
TLR4 AGONIST | VIRUS | POTENCY | PHARMACOLOGY & PHARMACY | MICE | TH1 | CHEMISTRY, MULTIDISCIPLINARY | ANTIGEN | Imidazoles - immunology | Quinolines - immunology | Toll-Like Receptor 7 - metabolism | Nanoparticles - chemistry | Drug Stability | Humans | Mice, Inbred C57BL | Quinolines - chemistry | AIDS Vaccines - immunology | Imidazoles - chemistry | Particle Size | Lipids - chemistry | Animals | Adsorption | Immunity, Humoral | Adjuvants, Immunologic - chemistry | Aluminum Hydroxide - chemistry | Surface Properties | Ligands | Mice | Tuberculosis Vaccines - immunology | Aluminum Oxide - chemistry | Immunity, Cellular | Toll-Like Receptor 8 - metabolism | Antigens | Tuberculosis vaccines | Papillomavirus infections | Drugs | Drug delivery systems | Tuberculosis | Vehicles | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8
by Corden, Keith B and Gorski, Kevin S and Gibson, Sheila J and Kedl, Ross M and Kieper, William C and Qiu, Xiaohong and Tomai, Mark A and Alkan, Sefik S and Vasilakos, John P
Journal of Immunology, ISSN 0022-1767, 02/2005, Volume 174, Issue 3, pp. 1259 - 1268
Although TLR7 and TLR8 are phylogenetically and structurally related, their relative functions are largely unknown. The role of TLR7 has been established using... 
PLASMACYTOID DENDRITIC CELLS | IMMUNE-RESPONSE | RECOGNITION | SIGNALING PATHWAY | TOLL-LIKE RECEPTORS | BACTERIAL FLAGELLIN | IMMUNOLOGY | NF-KAPPA-B | INNATE IMMUNITY | CUTTING EDGE | IFN-ALPHA | Leukocytes, Mononuclear - metabolism | Aminoquinolines - chemical synthesis | Imiquimod | Dendritic Cells - immunology | Humans | Monocytes - metabolism | Monocytes - immunology | Toll-Like Receptor 7 | Toll-Like Receptor 8 | Toll-Like Receptors | Membrane Glycoproteins - physiology | Transfection | Myeloid Cells - immunology | Leukocytes, Mononuclear - immunology | Dendritic Cells - drug effects | Myeloid Cells - drug effects | Receptors, Cell Surface - physiology | Imidazoles - chemical synthesis | Aminoquinolines - pharmacology | Dendritic Cells - metabolism | Interleukin-12 - biosynthesis | Cell Line | Leukocytes, Mononuclear - drug effects | Interferon-alpha - biosynthesis | Cells, Cultured | Membrane Glycoproteins - agonists | Receptors, Cell Surface - agonists | Imidazoles - pharmacology | Monocytes - drug effects | Myeloid Cells - metabolism | Tumor Necrosis Factor-alpha - biosynthesis | Cytokines - biosynthesis | Cell Lineage - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text TCT-350 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting - First 400 Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry
by Lee, Michael and Wlodarczak, Adrian and Bennett, Johan and Torzewski, Jan and Haude, Michael and Vrolix, Mathias and Buck, Thomas and Aminian, Adel and van der Schaaf, Rene and Nuruddin, Amin Ariff and Wiemer, Marcus and Yan, Bryan and van der Heyden, Jan and Toelg, Ralph and Merkely, Bela and Erglis, Andrejs and Brachmann, Johannes and Carrié, Didier and Zweiker, Robert and Achenbach, Stephan and Philipp, Sebastian and Tan, Huay Cheem and Webster, Mark and Jepson, Nigel and Nguyen, Michael and Eeckhout, Eric and Minden, Hans-Heinrich and Valina, Christian and Sabate, Manel and Schmitz, Thomas and Ruiz-Salmeron, Rafael Jose and Liebetrau, Christoph and Tomai, Fabrizio and Nef, Holger and Zeitz, Christopher and Jessurun, Gillian A and Fajadet, Jean and Menon, Madhav and Erlinge, David and Cequier, Angel and Landmesser, Ulf and Kische, Stephan and Moccetti, Marco and Mühlen, Constantin von zur and Wöhrle, Jochen and Eberli, Franz and Barlis, Peter and Ince, Hüseyin and victor legrand and Mcclean, Dougal and Assali, Abid and Ebelt, Henning and Christiansen, Evald and Friedrich, Guy and Jung, Werner and Graf, Kristof and Cassel, Graham and Möllmann, Helge and Lang, Irene and Schmeisser, Alexander and Westermann, Dirk and Cuculi, Florim and Ebrahim, Iftikhar and Carlo Trani and Jensen, Lisette Okkels and Winterhalter, Martin and Darius, Harald and Magro, Michael and Verheye, Stefan
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2018, Volume 72, Issue 13, pp. B142 - B143
Thrombosis | Magnesium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Abstract 4697: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment and holds potential for combination with immune checkpoint inhibitors
by Mullins, Stefanie R and Vogel, Katharina and Vasilakos, John and Grigsby, Iwen and Dovedi, Simon and Patricia, Ryan and Cooper, Zachary and Herbst, Ronald and Kumar, Rakesh and Tomai, Mark and Wilkinson, Robert W
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 4697 - 4697
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Topically Applied Imiquimod Inhibits Vascular Tumor Growth In Vivo
by Sidbury, Robert and Neuschler, Erin and Neuschler, Nicole and Sun, Ping and Wang, Xiao-qi and Puscasiu, Elena and Gugneja, Sajiv and Miller, Richard and Tomai, Mark and Paller, Amy S
Journal of Investigative Dermatology, ISSN 0022-202X, 11/2003, Volume 121, Issue 5, pp. 1205 - 1209
Vascular tumors occur in approximately 10% of all infants and may be associated with significant morbidity. Available therapies for vascular tumors, such as... 
cytokines | hemangioendothelioma | neoplasm | Neoplasm | Cytokines | Hemangioendothelioma | APOPTOSIS | ANGIOGENESIS | MOUSE | MODEL | DERMATOLOGY | MATRIX METALLOPROTEINASES | OVEREXPRESSION | INFANTILE HEMANGIOMA | TISSUE INHIBITOR | INVOLUTION | INFANCY | Apoptosis - drug effects | Aminoquinolines - administration & dosage | Proliferating Cell Nuclear Antigen - analysis | Antineoplastic Agents - administration & dosage | Hemangioendothelioma - drug therapy | Matrix Metalloproteinase 9 - metabolism | Animals | Hemangioendothelioma - pathology | Tissue Inhibitor of Metalloproteinase-1 - analysis | Female | Mice | Administration, Topical | Aminoquinolines - pharmacology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Abstract 711: Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
by Mullins, Stefanie R and Vasilakos, John and Deschler, Katharina and Grigsby, Iwen and Ren, Song and Elder, Matthew J and Dovedi, Simon J and Leishman, Andrew J and Ryan, Patricia and Cooper, Zachary and Elvecrog, James and Herbst, Ronald and Kumar, Rakesh and Tomai, Mark and Wilkinson, Robert W
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 711 - 711
Journal Article